No active 13F manager changed its position in FETUSD last quarter. No recent Form 4 insider filings for FETUSD.
No leg leans either way.
1 tracked 13F filer discloses a position in FETUSD as of the latest SEC 13F filings, a combined $0 in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Huntington National Bank | 1 | $0 | —Held | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Company | Co-held by | Their position there |
|---|---|---|
| Exxon Mobil CorpXOM | 77 funds | $46.8B |
| Marathon Petroleum CorpMPC | 77 funds | $5.3B |
| Chevron CorpCVX | 76 funds | $31.5B |
| Halliburton CoHAL | 76 funds | $7.2B |
| Apple IncAAPL | 75 funds | $115.3B |
| JPMorgan Chase & CoJPM | 75 funds | $57.8B |
| Johnson & JohnsonJNJ | 75 funds | $57.7B |
| Merck & Co. Inc.MRK | 75 funds | $33.6B |
| Unitedhealth Group IncUNH | 75 funds | $31.4B |
| Qualcomm IncQCOM | 75 funds | $16.9B |
| Bristol-Myers Squibb CoBMY | 75 funds | $15.2B |
| Abbvie IncABBV | 75 funds | $15.0B |
Ranked by how many of FETUSD's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in FETUSD.
No open-market insider transactions on file yet. Grants, gifts, and exercises live on the full insider page.
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 0 | 0 | – |
Insiders Form 4 open-market | 0 | 0 | $0 |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
| Class | 13F holders | Value held |
|---|---|---|
| FETcs | 150 funds | $478.6M |
| FETUSDthis pageCOMMON STOCK | 1 funds | $0 |
Same issuer, multiple share classes. The consensus leaderboards count this company once across all classes; this is the per-class detail.
No filings captured for this ticker in the live stream yet.
Connected entities for FETUSD
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/FETUSD/capital-change-brief"
Use Arkolith's capital_change_brief for FETUSD. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + the live filing stream, joined for FETUSD. Filings are public domain, sourced to SEC EDGAR.